Tweet
Influenza Other Respir Viruses. 2015 Oct 27. doi: 10.1111/irv.12355. [Epub ahead of print]
Survey of influenza and other respiratory viruses diagnostic testing in US hospitals, 2012-13.
Su S1,2, Fry AM1, Kirley PD3, Aragon D4, Yousey-Hindes K5, Meek J5, Openo K6, Oni O7, Sharangpani R8, Morin C9, Hollick G10, Lung K11, Laidler M12, Lindegren ML13, Schaffner W13, Atkinson A14, Chaves SS1.
Author information
Abstract
We sought to assess diagnostic practices for influenza and other respiratory virus in a survey of hospitals and laboratories participating in the US Influenza Hospitalization Surveillance Network in 2012-13. Of the 240 participating laboratories, 67% relied only on commercially-available rapid influenza diagnostic tests to diagnose influenza. Few reported the availability of molecular diagnostic assays for detection of influenza (26%) and other viral pathogens (≤ 20%) in hospitals and commercial laboratories. Reliance on insensitive assays to detect influenza may detract from optimal clinical management of influenza infections in hospitals. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
KEYWORDS:
EIP ; FluSurv-NET; Influenza; laboratory capacity; respiratory viruses
PMID: 26505742 [PubMed - as supplied by publisher]
Survey of influenza and other respiratory viruses diagnostic testing in US hospitals, 2012-13.
Su S1,2, Fry AM1, Kirley PD3, Aragon D4, Yousey-Hindes K5, Meek J5, Openo K6, Oni O7, Sharangpani R8, Morin C9, Hollick G10, Lung K11, Laidler M12, Lindegren ML13, Schaffner W13, Atkinson A14, Chaves SS1.
Author information
Abstract
We sought to assess diagnostic practices for influenza and other respiratory virus in a survey of hospitals and laboratories participating in the US Influenza Hospitalization Surveillance Network in 2012-13. Of the 240 participating laboratories, 67% relied only on commercially-available rapid influenza diagnostic tests to diagnose influenza. Few reported the availability of molecular diagnostic assays for detection of influenza (26%) and other viral pathogens (≤ 20%) in hospitals and commercial laboratories. Reliance on insensitive assays to detect influenza may detract from optimal clinical management of influenza infections in hospitals. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
KEYWORDS:
EIP ; FluSurv-NET; Influenza; laboratory capacity; respiratory viruses
PMID: 26505742 [PubMed - as supplied by publisher]